Meridian Wealth Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-27,248
Closed -$2.36M 218
2026
Q1
$2.36M Buy
+27,248
New +$2.61M 0.31% 65
2025
Q4
Sell
-2,330
Closed -$222K 192
2025
Q3
$222K Sell
2,330
-206
-8% -$18.9K 0.03% 173
2025
Q2
$221K Sell
2,536
-568
-18% -$48.2K 0.04% 169
2025
Q1
$279K Sell
3,104
-615
-17% -$55K 0.05% 150
2024
Q4
$297K Sell
3,719
-133
-3% -$11.5K 0.05% 146
2024
Q3
$347K Sell
3,852
-812
-17% -$68.3K 0.06% 139
2024
Q2
$367K Buy
4,664
+235
+5% +$19.3K 0.07% 134
2024
Q1
$386K Buy
4,429
+60
+1% +$5.12K 0.07% 127
2023
Q4
$360K Sell
4,369
-1,061
-20% -$80.9K 0.08% 130
2023
Q3
$425K Sell
5,430
-1,000
-16% -$83.7K 0.11% 113
2023
Q2
$566K Buy
6,430
+29
+0.5% +$2.5K 0.14% 101
2023
Q1
$516K Buy
6,401
+723
+13% +$58.9K 0.13% 110
2022
Q4
$441K Sell
5,678
-1,546
-21% -$125K 0.11% 122
2022
Q3
$583K Sell
7,224
-198
-3% -$17.8K 0.16% 100
2022
Q2
$666K Sell
7,422
-1,705
-19% -$173K 0.18% 104
2022
Q1
$1.01M Buy
9,127
+1,957
+27% +$207K 0.23% 85
2021
Q4
$742K Sell
7,170
-443
-6% -$51.3K 0.18% 101
2021
Q3
$954K Buy
7,613
+452
+6% +$58.5K 0.27% 81
2021
Q2
$889K Buy
7,161
+1,679
+31% +$211K 0.25% 84
2021
Q1
$648K Sell
5,482
-1,734
-24% -$203K 0.22% 91
2020
Q4
$845K Sell
7,216
-5,032
-41% -$554K 0.31% 71
2020
Q3
$1.27M Sell
12,248
-526
-4% -$52.8K 0.55% 42
2020
Q2
$1.17M Buy
12,774
+3,266
+34% +$313K 0.54% 43
2020
Q1
$857K Sell
9,508
-2,912
-23% -$310K 0.47% 44
2019
Q4
$1.41M Sell
12,420
-247
-2% -$27.1K 0.56% 33
2019
Q3
$1.38M Buy
12,667
+7,846
+163% +$819K 0.59% 35
2019
Q2
$497K Buy
4,821
+396
+9% +$36.2K 0.35% 65
2019
Q1
$403K Sell
4,425
-377
-8% -$33.7K 0.29% 74
2018
Q4
$437K Buy
+4,802
New +$449K 0.34% 60

Other funds holding MDT

Meridian Wealth Advisors's MDT Position: Q2 2026 in Review

Meridian Wealth Advisors sold out of Medtronic (MDT) in Q2 2026, closing a stake of 27,248 shares — an estimated $2.36M sold.

Meridian Wealth Advisors first reported a position in MDT in Q4 2018 and held it in 29 quarters. The position peaked at $2.36M in Q1 2026. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Meridian Wealth Advisors reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
  • Meridian Wealth Advisors sold 27,248 Medtronic shares in Q2 2026, an estimated $2.36M.
  • Meridian Wealth Advisors first reported a position in Medtronic in Q4 2018 and held it in 29 quarters.
  • Meridian Wealth Advisors's Medtronic position peaked at $2.36M in Q1 2026.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Meridian Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.